Correction to “Differences in the Cellular Response and Signaling

Addition and Correction pubs.acs.org/molecularpharmaceutics

Correction to “Differences in the Cellular Response and Signaling Pathways between Cisplatin and Monodentate Organometallic Ru(II) Antitumor Complexes Containing a Terphenyl Ligand” Anna Kisova, Lenka Zerzankova, Abraha Habtemariam, Peter J. Sadler, Viktor Brabec, and Jana Kasparkova* Mol. Pharmaceutics 2011, 8, (3), 949−957. DOI: 10.1021/mp200105d

I

n the original manuscript, there was an error in the Acknowledgment. The corrected Acknowledgment is herein included.

■

ACKNOWLEDGMENTS This work was supported by the Ministry of Education of the CR (Grants LC06030, OC09018), the Academy of Sciences of the CR (Grants M200040901), the Czech Science Foundation (Grants P303/11/P047, 301/09/H004), ERC (Grant 247450), and ERDF and AWM for Science City funding. The authors also acknowledge that their participation in the EU COST Action D39 has enabled them to exchange regularly their most recent ideas in the field of anticancer metallodrugs with several European colleagues.

Published: February 10, 2012 © 2012 American Chemical Society

694

dx.doi.org/10.1021/mp300064z | Mol. Pharmaceutics 2012, 9, 694−694